MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
gain
-$2,904K
(86.34%↑ Y/Y)
Foreign currency
translation adjustment
-$496K
(-130.17%↓ Y/Y)
Net gain
attributable to common...
-$3,400K
(82.66%↑ Y/Y)
Change in fair value of
derivative liabilities
$9,416K
(635.63%↑ Y/Y)
Change in fair value of
convertible notes
$5,235K
(41.60%↑ Y/Y)
Settlement gain
$2,250K
Change in fair value of
share payable
$201K
(973.91%↑ Y/Y)
Net gain
-$3,069K
(84.13%↑ Y/Y)
Deemed dividend
related to warrant...
$331K
(24.91%↑ Y/Y)
Total other income
(expense)
$7,831K
(485.38%↑ Y/Y)
Loss from
extinguishment of debt
-$4,756K
(34.69%↑ Y/Y)
Interest expense
$2,346K
(46.44%↑ Y/Y)
Foreign currency
transaction gain (loss)
-$1,344K
(-170.81%↓ Y/Y)
Loss from issuance of
debt
-$738K
Inducement expense
$87K
Loss from operations
-$10,900K
(37.03%↑ Y/Y)
Research and other
$494K
(31.73%↑ Y/Y)
Total operating costs
and expenses
$11,394K
(-35.58%↓ Y/Y)
General and
administrative
$6,536K
(-29.98%↓ Y/Y)
Research and development
$4,858K
(-41.83%↓ Y/Y)
Back
Back
Income Statement
NORTHWEST BIOTHERAPEUTICS INC (NWBO)
NORTHWEST BIOTHERAPEUTICS INC (NWBO)
source: myfinsight.com